LNTH-2503 / Medical University of Innsbruck, Lantheus - LARVOL DELTA

Evergreen Theragnostics announces licensing of EVG321 from Medical University of Innsbruck and enters clinical development of Radioligand Therapies in small cell lung cancer (PRNewswire) - "Evergreen Theragnostics...announced that they have entered into a collaboration and licensing-agreement with the Medical University of Innsbruck (MUI)....The agreement covers the clinical development of EVG321, a novel radioligand therapy (RLT) for small cell lung cancer (SCLC), targeting the cholecystokinin 2 receptor (CCK2R)....Over the next months, Evergreen intends to begin registration enabling therapeutic and diagnostic clinical trials for Lutetium-177 (¹⁷⁷Lu) EVG321 and Gallium-68 (⁶⁸Ga) EVG321. If successful, EVG321 could offer new hope to patients with small cell lung cancer."

Licensing / partnership • New trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor

Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Services (PRNewswire) - "Evergreen Theragnostics, Inc...announced the successful completion of a $26M capital raise supported both by existing shareholders and new institutional investors, Petrichor and LIFTT. The financing advances Evergreen's novel discovery pipeline into clinical trials, supports commercialization of its diagnostic agent, and further expands CDMO capabilities to meet growing client demand....'As we continue to work with the FDA on approval of our Ga-68 DOTATOC diagnostic kit, this new funding will enable us to rapidly progress our novel theragnostic pair, EVG-321, into clinical trials'....Evergreen Discovery also intends to begin registration enabling therapeutic and diagnostic clinical trials for Lutetium-177 (177Lu) EVG-321 and Gallium-68 (68Ga) EVG-321, a novel radiopharmaceutical theragnostic pair, which, if successful, could offer new hope to patients with small cell lung cancer."

Financing • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor